Glaukos Corp(GKOS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GKOS Glaukos Corp

未开盘 08-29 16:00:00 EDT

95.82

-0.74

-0.77%

盘后95.82

+0.000.00%

16:20 EDT

最高97.00	最低94.99	成交量48.85万
今开96.09	昨收96.56	日振幅2.08%
总市值54.95亿	流通市值53.09亿	总股本5,735万
成交额4,679万	换手率0.88%	流通股本5,540万
市净率7.18	ROE-12.98%	每股收益-1.65
52周最高163.71	52周最低77.10	市盈率-57.96
股息0.00	股息收益率0.00	ROA-6.34%

北京优虎网络科技有限公司

{"stockData":{"symbol":"GKOS","market":"US","secType":"STK","nameCN":"Glaukos Corp","latestPrice":95.82,"timestamp":1756497600000,"preClose":96.56,"halted":0,"volume":488453,"hourTrading":{"tag":"盘后","latestPrice":95.82,"preClose":95.82,"latestTime":"16:20 EDT","volume":24551,"amount":2352476.82,"timestamp":1756498825294},"delay":0,"floatShares":55401390,"shares":57349987,"eps":-1.653118,"marketStatus":"未开盘","change":-0.74,"latestTime":"08-29 16:00:00 EDT","open":96.09,"high":97,"low":94.99,"amount":46786219.051705,"amplitude":0.020816,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.653118,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1756800000000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1435204800000,"exchange":"NYSE","adjPreClose":96.56,"preHourTrading":{"tag":"盘前","latestPrice":96.64,"preClose":96.65,"latestTime":"05:47 EDT","volume":172,"amount":16581.57056,"timestamp":1756460866540},"postHourTrading":{"tag":"盘后","latestPrice":95.82,"preClose":95.82,"latestTime":"16:20 EDT","volume":24551,"amount":2352476.82,"timestamp":1756498825294},"volumeRatio":0.8676128138713328,"impliedVol":0.4819,"impliedVolPercentile":0.3614},"requestUrl":"/m/hq/s/GKOS","defaultTab":"news","newsList":[{"id":"2556784808","title":"Glaukos Corporation2025财年第二财季实现净利润-19.66百万美元，同比增加61.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556784808","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556784808?lang=zh_cn&edition=full","pubTime":"2025-08-04 00:01","pubTimestamp":1754236867,"startTime":"0","endTime":"0","summary":"8月4日，Glaukos Corporation公布财报，公告显示公司2025财年第二财季净利润为-19.66百万美元，同比增加61.11%；其中营业收入为1.24亿美元，同比增加29.59%，每股基本收益为-0.34美元。从资产负债表来看，Glaukos Corporation总负债2.22亿美元，其中短期债务--，资产负债比为4.45，流动比率为0.06。机构评级：截至2025年8月4日，当前有13家机构对Glaukos Corporation目标价做出预测，其中目标均价为122.46美元，其中最低目标价为72.00美元，最高目标价为165.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804000231a472bcce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804000231a472bcce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GKOS"],"gpt_icon":0},{"id":"1176545036","title":"异动解读 | 眼科医疗公司Glaukos股价盘中大跌5.03%，多家券商调整目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1176545036","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176545036?lang=zh_cn&edition=full","pubTime":"2025-07-31 21:51","pubTimestamp":1753969886,"startTime":"0","endTime":"0","summary":"周四盘中，眼科医疗设备公司Glaukos Corp股价出现大幅下跌，截至盘中跌幅达5.03%。造成Glaukos股价下跌的原因可能与多家知名投资银行对该公司的最新评级调整有关。此外，瑞穗证券也将Glaukos的目标价从150美元下调至130美元，富国银行则将目标价从86美元上调至92美元。这些不同方向的目标价调整反映了分析师对Glaukos未来前景看法的分歧。市场将继续关注Glaukos的后续表现，以及公司能否通过强劲的业绩来重新赢得投资者的信心。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GKOS"],"gpt_icon":0},{"id":"2551126348","title":"Glaukos Corporation涨1.78% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2551126348","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551126348?lang=zh_cn&edition=full","pubTime":"2025-07-16 22:03","pubTimestamp":1752674586,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日22时03分，Glaukos Corporation股票出现异动，股价急速拉升1.78%。截至发稿，该股报100.01美元/股，成交量4.41万股，换手率0.08%，振幅1.42%。Glaukos Corporation股票所在的医疗器械行业中，整体跌幅为0.09%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科制药和医疗技术公司，专注于开发用于青光眼、角膜疾病和视网膜疾病治疗的新型、无滴疗法和商业化相关产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716220307a6adaefc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716220307a6adaefc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GKOS","IE0009354923.USD","LU1878469433.USD","BK4548","LU2065731478.USD","BK4082"],"gpt_icon":0},{"id":"2551198155","title":"Glaukos Corporation跌4.50% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2551198155","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551198155?lang=zh_cn&edition=full","pubTime":"2025-07-15 21:39","pubTimestamp":1752586783,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日21时39分，Glaukos Corporation股票出现波动，股价快速跳水4.50%。截至发稿，该股报99.50美元/股，成交量2.6731万股，换手率0.05%，振幅2.78%。Glaukos Corporation股票所在的医疗器械行业中，整体涨幅为0.13%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科制药和医疗技术公司，专注于开发用于青光眼、角膜疾病和视网膜疾病治疗的新型、无滴疗法和商业化相关产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071521394395438ad5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071521394395438ad5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","IE0009354923.USD","LU2065731478.USD","BK4082","LU1878469433.USD","GKOS"],"gpt_icon":0},{"id":"2546258536","title":"Glaukos Corporation涨3.34% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2546258536","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546258536?lang=zh_cn&edition=full","pubTime":"2025-06-25 03:33","pubTimestamp":1750793603,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日03时33分，Glaukos Corporation股票出现异动，股价快速拉升3.34%。截至发稿，该股报100.04美元/股，成交量28.232万股，换手率0.49%，振幅3.29%。Glaukos Corporation股票所在的医疗器械行业中，整体涨幅为2.24%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科制药和医疗技术公司，专注于开发用于青光眼、角膜疾病和视网膜疾病治疗的新型、无滴疗法和商业化相关产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625033324978d40d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625033324978d40d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","GKOS","IE0009354923.USD","LU2065731478.USD","BK4082","BK4548"],"gpt_icon":0},{"id":"2545709191","title":"Glaukos Corporation跌2.29% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2545709191","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545709191?lang=zh_cn&edition=full","pubTime":"2025-06-21 03:47","pubTimestamp":1750448844,"startTime":"0","endTime":"0","summary":"北京时间2025年06月21日03时47分，Glaukos Corporation股票出现异动，股价急速下跌2.29%。截至发稿，该股报100.00美元/股，成交量89.6033万股，换手率1.57%，振幅2.72%。Glaukos Corporation股票所在的医疗器械行业中，整体涨幅为0.12%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科制药和医疗技术公司，专注于开发用于青光眼、角膜疾病和视网膜疾病治疗的新型、无滴疗法和商业化相关产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621034724a7151596&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621034724a7151596&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GKOS","IE0009354923.USD","LU1878469433.USD","BK4548","LU2065731478.USD","BK4082"],"gpt_icon":0},{"id":"2543608274","title":"Glaukos Corporation涨2.64% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2543608274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543608274?lang=zh_cn&edition=full","pubTime":"2025-06-16 21:36","pubTimestamp":1750081006,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日21时36分，Glaukos Corporation股票出现波动，股价急速上涨2.64%。截至发稿，该股报100.18美元/股，成交量4.2103万股，换手率0.07%，振幅1.50%。Glaukos Corporation股票所在的医疗器械行业中，整体涨幅为0.34%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科制药和医疗技术公司，专注于开发用于青光眼、角膜疾病和视网膜疾病治疗的新型、无滴疗法和商业化相关产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506162136469781ed99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506162136469781ed99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0009354923.USD","BK4548","BK4082","GKOS","LU1878469433.USD","LU2065731478.USD"],"gpt_icon":0},{"id":"2542713535","title":"Glaukos Corporation涨4.60% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2542713535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542713535?lang=zh_cn&edition=full","pubTime":"2025-06-11 23:12","pubTimestamp":1749654744,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日23时12分，Glaukos Corporation股票出现波动，股价急速拉升4.60%。截至发稿，该股报100.04美元/股，成交量33.3344万股，换手率0.58%，振幅4.05%。Glaukos Corporation股票所在的医疗器械行业中，整体涨幅为0.04%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科制药和医疗技术公司，专注于开发用于青光眼、角膜疾病和视网膜疾病治疗的新型、无滴疗法和商业化相关产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061123122595180352&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061123122595180352&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","GKOS","BK4082","BK4548","LU2065731478.USD","IE0009354923.USD"],"gpt_icon":0},{"id":"2538467959","title":"Glaukos Corporation涨4.30% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2538467959","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538467959?lang=zh_cn&edition=full","pubTime":"2025-05-27 22:06","pubTimestamp":1748354818,"startTime":"0","endTime":"0","summary":"北京时间2025年05月27日22时06分，Glaukos Corporation股票出现异动，股价快速拉升4.30%。截至发稿，该股报100.15美元/股，成交量7.5264万股，换手率0.13%，振幅2.50%。Glaukos Corporation股票所在的医疗器械行业中，整体涨幅为1.31%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科制药和医疗技术公司，专注于开发用于青光眼、角膜疾病和视网膜疾病治疗的新型、无滴疗法和商业化相关产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527220659a48e7cb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527220659a48e7cb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GKOS","IE0009354923.USD","BK4082","LU1878469433.USD","LU2065731478.USD","BK4548"],"gpt_icon":0},{"id":"2533653571","title":"大摩：维持Glaukos(GKOS.US)评级，由减持调整至减持评级, 目标价由110.00美元调整至72.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2533653571","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533653571?lang=zh_cn&edition=full","pubTime":"2025-05-06 22:43","pubTimestamp":1746542637,"startTime":"0","endTime":"0","summary":"大摩：维持Glaukos(GKOS.US)评级，由减持调整至减持评级, 目标价由110.00美元调整至72.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/06224350176366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GKOS"],"gpt_icon":0},{"id":"1161779164","title":"异动解读 | Glaukos股价盘中大涨7.21%，分析师维持\"买入\"评级","url":"https://stock-news.laohu8.com/highlight/detail?id=1161779164","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161779164?lang=zh_cn&edition=full","pubTime":"2025-05-03 03:32","pubTimestamp":1746214358,"startTime":"0","endTime":"0","summary":"周五盘中，眼科医疗技术公司Glaukos Corp股价出现显著上涨，涨幅达7.21%，引起投资者广泛关注。这一涨势可能与Stephens & Co.最新发布的分析报告有关。该机构维持了对Glaukos的\"买入\"评级，尽管将目标价从140.00美元下调至115.00美元。Glaukos Corp是一家专注于开发创新眼科治疗方案的公司，主要针对青光眼、角膜疾病和视网膜疾病。此外，Glaukos还提供多种微创手术器械产品，如iStent、iStent inject W和iStent infinite，进一步巩固了其在眼科医疗器械市场的地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Glaukos股价盘中大涨7.21%，分析师维持\"买入\"评级","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GKOS"],"gpt_icon":0},{"id":"2532279268","title":"Stephens & Co.：维持Glaukos(GKOS.US)评级，由增持调整至增持评级, 目标价由140.00美元调整至115.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532279268","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532279268?lang=zh_cn&edition=full","pubTime":"2025-05-03 01:02","pubTimestamp":1746205361,"startTime":"0","endTime":"0","summary":"Stephens & Co.：维持Glaukos(GKOS.US)评级，由增持调整至增持评级, 目标价由140.00美元调整至115.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/03010250110399.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GKOS"],"gpt_icon":0},{"id":"2532007701","title":"Stifel：维持Glaukos(GKOS.US)评级，由买入调整至买入评级, 目标价由140.00美元调整至115.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532007701","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532007701?lang=zh_cn&edition=full","pubTime":"2025-05-02 00:11","pubTimestamp":1746115901,"startTime":"0","endTime":"0","summary":"Stifel：维持Glaukos(GKOS.US)评级，由买入调整至买入评级, 目标价由140.00美元调整至115.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/02001150084810.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GKOS"],"gpt_icon":0},{"id":"1120239980","title":"异动解读 | 格劳科斯股价盘中暴跌11.62%，多家投行大幅下调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1120239980","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120239980?lang=zh_cn&edition=full","pubTime":"2025-05-01 21:45","pubTimestamp":1746107147,"startTime":"0","endTime":"0","summary":"格劳科斯公司周四盘中股价暴跌11.62%，主要受到多家知名投资银行大幅下调目标价的影响。据最新消息，摩根大通对格劳科斯的目标价做出了最大幅度的调整，将其从此前的160美元大幅下调至100美元，降幅高达37.5%。这些知名投资银行的一致行动引发了投资者对格劳科斯未来前景的担忧，导致其股价在盘中出现大幅下跌。格劳科斯作为一家专注于开发和商业化用于治疗青光眼的创新技术的医疗器械公司，其股价表现一直受到市场密切关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GKOS"],"gpt_icon":0},{"id":"2532008223","title":"Glaukos Corporation盘中异动 大幅跳水11.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532008223","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532008223?lang=zh_cn&edition=full","pubTime":"2025-05-01 21:33","pubTimestamp":1746106408,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日21时33分，Glaukos Corporation股票出现波动，股价大幅下跌11.33%。Glaukos Corporation股票所在的医疗器械行业中，整体跌幅为0.88%。其相关个股中，Nanovibronix, Inc.、Conmed Corporation、Tandem Diabetes Care, Inc.涨幅较大，Nanovibronix, Inc.、Bluejay Diagnostics, Inc.、Invo Fertility, Inc.较为活跃，换手率分别为1433.01%、226.08%、80.98%，振幅较大的相关个股有Pulmonx Corporation、Nanovibronix, Inc.、Zimvie Inc.，振幅分别为15.71%、9.93%、8.83%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科制药和医疗技术公司，专注于开发用于青光眼、角膜疾病和视网膜疾病治疗的新型、无滴疗法和商业化相关产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213328a6d011ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213328a6d011ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GKOS","IE0009354923.USD","BK4082","LU1878469433.USD","LU2065731478.USD","BK4548"],"gpt_icon":0},{"id":"2532727270","title":"富国银行：下调Glaukos(GKOS.US)评级，由增持调整至持股观望评级, 目标价由160.00美元调整至86.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532727270","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532727270?lang=zh_cn&edition=full","pubTime":"2025-05-01 20:59","pubTimestamp":1746104359,"startTime":"0","endTime":"0","summary":"富国银行：下调Glaukos(GKOS.US)评级，由增持调整至持股观望评级, 目标价由160.00美元调整至86.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/01205950082917.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GKOS"],"gpt_icon":0},{"id":"2532807956","title":"Needham：维持Glaukos(GKOS.US)评级，由买入调整至买入评级, 目标价由176.00美元调整至115.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532807956","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532807956?lang=zh_cn&edition=full","pubTime":"2025-05-01 19:44","pubTimestamp":1746099899,"startTime":"0","endTime":"0","summary":"Needham：维持Glaukos(GKOS.US)评级，由买入调整至买入评级, 目标价由176.00美元调整至115.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/01194450081279.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GKOS"],"gpt_icon":0},{"id":"1193923136","title":"异动解读 | Glaukos股价盘前大跌8.74%，分析师大幅下调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1193923136","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193923136?lang=zh_cn&edition=full","pubTime":"2025-05-01 19:02","pubTimestamp":1746097367,"startTime":"0","endTime":"0","summary":"Glaukos Corp周四盘前股价大跌8.74%，引起投资者广泛关注。这一显著跌幅似乎与多家知名投资银行下调该公司目标股价有关。根据最新消息，摩根大通大幅下调了Glaukos的目标价，从此前的160美元骤降至100美元，降幅高达37.5%。作为一家专注于开发和商业化用于治疗青光眼的创新技术的医疗器械公司，Glaukos的股价表现一直受到市场密切关注。投资者应密切关注公司接下来的公告和财报，以更好地理解这次股价调整背后的具体原因。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GKOS"],"gpt_icon":0},{"id":"1103631356","title":"异动解读 | 格劳科斯股价盘前大跌8.74%，多家券商下调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1103631356","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103631356?lang=zh_cn&edition=full","pubTime":"2025-05-01 19:02","pubTimestamp":1746097363,"startTime":"0","endTime":"0","summary":"格劳科斯公司周四盘前股价大跌8.74%，主要受到多家券商下调目标价的影响。据悉，摩根大通将格劳科斯的目标价从160美元大幅下调至100美元，降幅高达37.5%。分析人士指出，尽管目前尚不清楚券商下调目标价的具体原因，但这可能反映出他们对格劳科斯公司近期业务表现或行业环境的看法发生了变化。投资者应密切关注公司未来的财报表现和业务发展，以评估这一价格调整是否合理。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 格劳科斯股价盘前大跌8.74%，多家券商下调目标价","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GKOS"],"gpt_icon":0},{"id":"1139147118","title":"异动解读 | Glaukos股价盘后大跌6.63%，尽管季度业绩优于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1139147118","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139147118?lang=zh_cn&edition=full","pubTime":"2025-05-01 05:20","pubTimestamp":1746048053,"startTime":"0","endTime":"0","summary":"医疗设备公司Glaukos Corp在发布第一季度财报后，股价在盘后交易中大跌6.63%。尽管公司的业绩超出了分析师的预期，但投资者似乎对公司的整体表现仍持谨慎态度。根据公司发布的财报，Glaukos在截至3月31日的季度中，调整后每股亏损为0.22美元，优于分析师平均预期的0.35美元亏损。尽管季度业绩优于预期，但投资者似乎更关注公司的长期发展前景。值得注意的是，Glaukos的股价今年以来已下跌37.4%，这可能反映了市场对公司持续亏损的担忧。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GKOS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.glaukos.com","stockEarnings":[{"period":"1week","weight":0.0177},{"period":"1month","weight":0.0188},{"period":"3month","weight":0.0162},{"period":"6month","weight":-0.2016},{"period":"1year","weight":-0.2773},{"period":"ytd","weight":-0.3609}],"compareEarnings":[{"period":"1week","weight":-0.0004},{"period":"1month","weight":0.0167},{"period":"3month","weight":0.0944},{"period":"6month","weight":0.0856},{"period":"1year","weight":0.1553},{"period":"ytd","weight":0.1006}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Glaukos Corporation于1998年7月14日在特拉华州注册成立。该公司是一家眼科制药和医疗技术公司，专注于开发新型无滴剂疗法，并将相关产品商业化，用于治疗青光眼、角膜疾病和视网膜疾病。他们首先开发了微创青光眼手术（MIGS）作为传统青光眼治疗模式的替代方案，并于2012年推出了他们的第一台MIGS设备。他们还提供商业化的专有生物激活药物疗法，用于治疗罕见的角膜疾病圆锥角膜，该疗法于2016年获得美国食品和药物管理局（FDA）的批准。他们正在开发一系列平台，以支持正在进行的制药和医疗器械创新。","yearOnYearQuotes":[{"month":1,"riseRate":0.9,"avgChangeRate":0.086384},{"month":2,"riseRate":0.6,"avgChangeRate":-0.00698},{"month":3,"riseRate":0.6,"avgChangeRate":-0.022683},{"month":4,"riseRate":0.5,"avgChangeRate":0.010953},{"month":5,"riseRate":0.6,"avgChangeRate":0.024636},{"month":6,"riseRate":0.9,"avgChangeRate":0.110675},{"month":7,"riseRate":0.636364,"avgChangeRate":0.018448},{"month":8,"riseRate":0.454545,"avgChangeRate":0.049318},{"month":9,"riseRate":0.4,"avgChangeRate":-0.020194},{"month":10,"riseRate":0.5,"avgChangeRate":-0.024992},{"month":11,"riseRate":0.5,"avgChangeRate":0.012839},{"month":12,"riseRate":0.5,"avgChangeRate":0.008639}],"exchange":"NYSE","name":"Glaukos Corp","nameEN":"Glaukos"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.9","shortVersion":"4.34.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Glaukos Corp(GKOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Glaukos Corp(GKOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Glaukos Corp,GKOS,Glaukos Corp股票,Glaukos Corp股票老虎,Glaukos Corp股票老虎国际,Glaukos Corp行情,Glaukos Corp股票行情,Glaukos Corp股价,Glaukos Corp股市,Glaukos Corp股票价格,Glaukos Corp股票交易,Glaukos Corp股票购买,Glaukos Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Glaukos Corp(GKOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Glaukos Corp(GKOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}